Literature DB >> 10623765

Isolation of transformation suppressor genes by cDNA subtraction: lumican suppresses transformation induced by v-src and v-K-ras.

N Yoshioka1, H Inoue, K Nakanishi, K Oka, M Yutsudo, A Yamashita, A Hakura, H Nojima.   

Abstract

We have reported that suppressive factors for transformation by viral oncogenes are expressed in primary rat embryo fibroblasts (REFs). To identify such transformation suppressor genes, we prepared a subtracted cDNA library by using REFs and a rat normal fibroblast cell line, F2408, and isolated 30 different cDNA clones whose mRNA expression was markedly reduced in F2408 cells relative to that in REFs. We referred to these as TRIF (transcript reduced in F2408) clones. Among these genes, we initially tested the suppressor activity for transformation on three TRIF genes, TRIF1 (neuronatin), TRIF2 (heparin-binding growth-associated molecule), and TRIF3 (lumican) by focus formation assay and found that lumican inhibited focus formation induced by activated H-ras in F2408 cells. Colony formation in soft agar induced by v-K-ras or v-src was also suppressed in F2408 clones stably expressing exogenous lumican without disturbing cell proliferation. Tumorigenicity in nude mice induced by these oncogenes was also suppressed in these lumican-expressing clones. These results indicate that lumican has the ability to suppress transformation by v-src and v-K-ras.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10623765      PMCID: PMC111623          DOI: 10.1128/jvi.74.2.1008-1013.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Large scale isolation of osteoclast-specific genes by an improved method involving the preparation of a subtracted cDNA library.

Authors:  M Kobori; Y Ikeda; H Nara; M Kato; M Kumegawa; H Nojima; H Kawashima
Journal:  Genes Cells       Date:  1998-07       Impact factor: 1.891

2.  Cooperative transforming activities of ras, myc, and src viral oncogenes in nonestablished rat adrenocortical cells.

Authors:  A MacAuley; T Pawson
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

3.  Expression of human proteoglycan in Chinese hamster ovary cells inhibits cell proliferation.

Authors:  Y Yamaguchi; E Ruoslahti
Journal:  Nature       Date:  1988-11-17       Impact factor: 49.962

4.  The p21 src genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family of normal vertebrate genes.

Authors:  R W Ellis; D Defeo; T Y Shih; M A Gonda; H A Young; N Tsuchida; D R Lowy; E M Scolnick
Journal:  Nature       Date:  1981-08-06       Impact factor: 49.962

Review 5.  Cellular oncogenes and multistep carcinogenesis.

Authors:  H Land; L F Parada; R A Weinberg
Journal:  Science       Date:  1983-11-18       Impact factor: 47.728

6.  Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes.

Authors:  H Land; L F Parada; R A Weinberg
Journal:  Nature       Date:  1983 Aug 18-24       Impact factor: 49.962

7.  Cellular responsiveness to growth factors correlates with a cell's ability to express the transformed phenotype.

Authors:  P L Kaplan; B Ozanne
Journal:  Cell       Date:  1983-07       Impact factor: 41.582

8.  Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture.

Authors:  H E Ruley
Journal:  Nature       Date:  1983 Aug 18-24       Impact factor: 49.962

9.  Rat mutant cells showing temperature sensitivity for transformation by wild-type Moloney murine sarcoma virus.

Authors:  H Inoue; M Yutsudo; A Hakura
Journal:  Virology       Date:  1983-02       Impact factor: 3.616

10.  Construction and isolation of a transforming murine retrovirus containing the src gene of Rous sarcoma virus.

Authors:  S M Anderson; E M Scolnick
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

View more
  18 in total

1.  Comprehensive isolation of meiosis-specific genes identifies novel proteins and unusual non-coding transcripts in Schizosaccharomyces pombe.

Authors:  T Watanabe; K Miyashita; T T Saito; T Yoneki; Y Kakihara; K Nabeshima; Y A Kishi; C Shimoda; H Nojima
Journal:  Nucleic Acids Res       Date:  2001-06-01       Impact factor: 16.971

Review 2.  The biology of small leucine-rich proteoglycans in bone pathophysiology.

Authors:  Dragana Nikitovic; John Aggelidakis; Marian F Young; Renato V Iozzo; Nikos K Karamanos; George N Tzanakakis
Journal:  J Biol Chem       Date:  2012-08-09       Impact factor: 5.157

Review 3.  Antithetic roles of proteoglycans in cancer.

Authors:  Elena Garusi; Silvia Rossi; Roberto Perris
Journal:  Cell Mol Life Sci       Date:  2011-10-02       Impact factor: 9.261

Review 4.  Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans.

Authors:  Renato V Iozzo; Liliana Schaefer
Journal:  FEBS J       Date:  2010-08-31       Impact factor: 5.542

5.  Lumican reduces tumor growth via induction of fas-mediated endothelial cell apoptosis.

Authors:  Kent E Williams; Logan A Fulford; Allan R Albig
Journal:  Cancer Microenviron       Date:  2010-11-18

Review 6.  Roles of lumican and keratocan on corneal transparency.

Authors:  Winston W-Y Kao; Chia-Yang Liu
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

7.  Differential analysis of CD4+ Th memory clones with identical T-cell receptor (TCR)-alphabeta rearrangement (non-transgenic), but distinct lymphokine phenotype, reveals diverse and novel gene expression.

Authors:  Christine M Graham; D Brian Thomas
Journal:  Immunology       Date:  2004-10       Impact factor: 7.397

Review 8.  Pathogenesis of human papillomaviruses in differentiating epithelia.

Authors:  Michelle S Longworth; Laimonis A Laimins
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

9.  Invasion of normal human fibroblasts induced by v-Fos is independent of proliferation, immortalization, and the tumor suppressors p16INK4a and p53.

Authors:  Linda A Scott; J Keith Vass; E Kenneth Parkinson; David A F Gillespie; Joseph N Winnie; Bradford W Ozanne
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

10.  Differential impact of tumor suppressor pathways on DNA damage response and therapy-induced transformation in a mouse primary cell model.

Authors:  A Kathleen McClendon; Jeffry L Dean; Adam Ertel; Erik S Knudsen
Journal:  PLoS One       Date:  2010-01-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.